I recently shared a BMJ report that outlined the approval of Esketamine in Europe: Since sharing this news, the following rapid response by the MHRA [The Medicines and Healthcare products … Continue reading Esketamine: Regulators and a confusing narrative
The BMJ has published this News report, the full article can be accessed here.
3rd October 2018, Fiona Godlee, Editor-in-Chief of the BMJ: “We need a Sunshine Act to ensure that payments are properly declared. We also need action from medicines’s leaders – the … Continue reading Sunshine, light, and the Royal College of Psychiatrists
Yesterday, on the 29th May 2018 I had my last revalidation as a doctor [though I will still have to complete annual appraisals until I retire in 2022]. My experience … Continue reading ‘We must look at the whole impact of revalidation’
The above meta-analysis was published in the Lancet today and I woke up to read headlines like this: The lead author, Andrea Cipriani, Department of Psychiatry, University of Oxford, … Continue reading Antidepressant prescribing: still much to learn
I do hope that Scotland’s Realistic Medicine campaign will consider all the points raised by Dr Louisa Polak in this letter to the BMJ:
The following analysis: “Surge in publications on early detection” was recently published in the BMJ. The authors concluded that “we need more critical thinking and more studies that specifically target both … Continue reading Early detection: “We need critical thinking”
There is a lot of effort in NHS Scotland to raise awareness amongst healthcare staff about delirium, using statements like this: Delirium is a very complex state and it is … Continue reading Yellow socks and handstands